Feds want warning labels on children's flu drugs

By: The Associated Press
By: The Associated Press

Federal health regulators are recommending new label warnings about neurological problems on a pair of children's flu drugs.

The Food and Drug Administration has released its safety review of Roche's Tamiflu and GlaxoSmithKline's Relenza. The FDA opened a safety probe of Tamiflu in 2005 after receiving reports of children experiencing hallucinations and convulsions.

Twenty-five patients under the age of 21 have died while taking the drug, most of them in Japan. Five died from "falling from windows or balconies or running into traffic."

No deaths have been connected with Relenza, but regulators say children taking the drug have shown similar neurological problems.

An outside group of pediatric experts is scheduled to open its own safety review next week.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WNDU - Channel 16 54516 State Road 933 South Bend, IN 46637 Front Desk: 574-284-3000 Newsroom: 574-284-3016 Email: newscenter16@wndu.com
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 11765346 - wndu.com/a?a=11765346
Gray Television, Inc.